Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 2379
IPSCIO Record ID: 237271
The Canadian Licensor will return or transfer to Licensee all data, information and materials including, without limitation, all pre-clinical and clinical study data and results, reports, records, market research, Confidential Information and all regulatory filings (e.g., all CTAs, Registration Applications and Registrations) (collectively, the Materials), together with all know-how, including Licensors Know-How, pertaining to the development and commercialization of Products and the Method as well as the Licensees Product,
To the extent required for Licensee to access Materials in the possession of third party contractors and collaboration partners engaged by Licensor or its Affiliates to perform services on its or their behalf including, without limitation, to conduct preclinical or clinical studies on Products and the Method as well as the Licensee Product; or market research on the Licensee Product, Licensor agrees to grant permission under any applicable agreement for such third parties to give access to Licensee Product in their possession.
Licensor and its Affiliates grant to Licensee an exclusive, irrevocable, right and license under the Licensor Intellectual Property to develop, make, have made, use, offer to sell, sell and have sold Products, the Method and the Licensee Product for all indications worldwide. The foregoing license shall include the right to grant sublicenses.
For the Protection of Proprietary Information. In addition to the foregoing, any Materials and know-how, including Licensor Know-How, pertaining to the development and commercialization of Products, the Method and Licensee Product, developed by Licensor, its Affiliates and/or their third party contractors or collaboration partners during the term of the Assignment (collectively, Proprietary Information) shall be deemed to be the confidential and proprietary information of Licensee as the disclosing party.
LevulanÂ®' shall mean Licensees brand of the chemical compound 5 – aminolevulinic acid HCI.
Levulan is indicated for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
IPSCIO Record ID: 1182
IPSCIO Record ID: 1634